Dabigatran
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Dabigatran Product Information
Dabigatran is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Dabigatran. The product is supplied by Clearsynth under CAT No. CS-O-03403.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Dabigatran
CAS No.
211914-51-1
CAT No.
CS-O-03403
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C25H25N7O3
Molecular Weight
471.51
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Dabigatran is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Dabigatran.
Overview
Dabigatran is a THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
Synonyms
Dabigatran
Application Notes
Dabigatran is a THROMBIN inhibitor which acts by binding and blocking thrombogenic activity and the prevention of thrombus formation. It is used to reduce the risk of stroke and systemic EMBOLISM in patients with nonvalvular atrial fibrillation.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.